These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31666986)

  • 1. Prophylactic treatment of osteoporosis after SCI: promising research, but not yet indicated.
    Anderson D; Park AJ
    Spinal Cord Ser Cases; 2019; 5():25. PubMed ID: 31666986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is prophylaxis for osteoporosis indicated after acute spinal cord injury?
    Dionyssiotis Y
    Spinal Cord Ser Cases; 2019; 5():24. PubMed ID: 31240120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies.
    Battaglino RA; Lazzari AA; Garshick E; Morse LR
    Curr Osteoporos Rep; 2012 Dec; 10(4):278-85. PubMed ID: 22983921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting osteoporosis medication receipt in Veterans with a spinal cord injury: A retrospective cohort study.
    Weaver FM; Le B; Ray C; Miskevics S; Gonzalez B; Carbone LD
    J Spinal Cord Med; 2019 Nov; 42(6):760-767. PubMed ID: 30888309
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of Bisphosphonate Therapy With Incident of Lower Extremity Fractures in Persons With Spinal Cord Injuries or Disorders.
    Carbone LD; Gonzalez B; Miskevics S; Ray C; Etingen B; Guihan M; Craven BC; George V; Weaver FM
    Arch Phys Med Rehabil; 2020 Apr; 101(4):633-641. PubMed ID: 31958428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone protective agents in children.
    Wood CL; Ahmed SF
    Arch Dis Child; 2018 May; 103(5):503-508. PubMed ID: 29066521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based prevention and treatment of osteoporosis after spinal cord injury: a systematic review.
    Soleyman-Jahi S; Yousefian A; Maheronnaghsh R; Shokraneh F; Zadegan SA; Soltani A; Hosseini SM; Vaccaro AR; Rahimi-Movaghar V
    Eur Spine J; 2018 Aug; 27(8):1798-1814. PubMed ID: 28497215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders.
    Abderhalden L; Weaver FM; Bethel M; Demirtas H; Burns S; Svircev J; Hoenig H; Lyles K; Miskevics S; Carbone LD
    Osteoporos Int; 2017 Mar; 28(3):925-934. PubMed ID: 27924381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis in Children with Chronic Illnesses: Diagnosis, Monitoring, and Treatment.
    Grover M; Bachrach LK
    Curr Osteoporos Rep; 2017 Aug; 15(4):271-282. PubMed ID: 28620868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteoporosis].
    Uebelhart B; Rizzoli R
    Rev Med Suisse; 2013 Jan; 9(369):125-31. PubMed ID: 23409650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Innovation of bisphosphonates for improvement of adherence.].
    Takeuchi Y
    Clin Calcium; 2017; 27(2):197-202. PubMed ID: 28123121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis after spinal cord injury: aetiology, effects and therapeutic approaches.
    Abdelrahman S; Ireland A; Winter EM; Purcell M; Coupaud S
    J Musculoskelet Neuronal Interact; 2021 Mar; 21(1):26-50. PubMed ID: 33657753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and management of osteoporosis and osteoporotic fractures in persons with a spinal cord injury or disorder: A systematic scoping review.
    Zleik N; Weaver F; Harmon RL; Le B; Radhakrishnan R; Jirau-Rosaly WD; Craven BC; Raiford M; Hill JN; Etingen B; Guihan M; Heggeness MH; Ray C; Carbone L
    J Spinal Cord Med; 2019 Nov; 42(6):735-759. PubMed ID: 29745791
    [No Abstract]   [Full Text] [Related]  

  • 14. Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury.
    Gifre L; Vidal J; Carrasco JL; Muxi A; Portell E; Monegal A; Guañabens N; Peris P
    Osteoporos Int; 2016 Jan; 27(1):405-10. PubMed ID: 26423406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.
    Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV
    Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis: a network meta-analysis.
    Jansen JP; Bergman GJ; Huels J; Olson M
    Semin Arthritis Rheum; 2011 Feb; 40(4):275-84.e1-2. PubMed ID: 20828791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Bisphosphonates on Managing Osteoporosis After Spinal Cord Injury: A Meta-Analysis.
    Xinghua J; Junjie W; Yao G; Peng S; Jianzhong H
    Curr Pharm Des; 2020; 26(39):5072-5078. PubMed ID: 32364066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Viswanathan M; Reddy S; Berkman N; Cullen K; Middleton JC; Nicholson WK; Kahwati LC
    JAMA; 2018 Jun; 319(24):2532-2551. PubMed ID: 29946734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-osteoporotic treatments in neurological diseases.
    Giannini S
    Funct Neurol; 2009; 24(1):41-4. PubMed ID: 19403053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatments for osteoporosis in people with a disability.
    Smith EM
    PM R; 2011 Feb; 3(2):143-52. PubMed ID: 21333953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.